Glonghui, Feb. 5 | Goldman Sachs released a report saying that MSD's revenue and profit for the fourth quarter of last year beat expectations. Revenue guidance for fiscal year 2024 was in line with expectations, while earnings per share guide beat expectations. Last quarter's results once again reflect the Group's ability to hand over strong sales data and perform best in the industry. I believe there is room for improvement in terms of core licensing and new product launches. There are still some underrated projects in the product line this year and next. Potential mergers and acquisitions and partnerships may further drive growth, raising its target price from $128 to $134, maintaining a “buy” rating.